Comparison between convective radiofrequency water vapor thermal ablation (REZUM) versus tamsulosin in management of lower urinary tract symptoms in patients with benign prostatic enlargement / (Record no. 173567)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 06083namaa22004331i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - أخر تعامل مع التسجيلة | |
| control field | 20250918115537.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 250816s2024 ua a|||frm||| 000 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloguing agency | EG-GICUC |
| Language of cataloging | eng |
| Transcribing agency | EG-GICUC |
| Modifying agency | EG-GICUC |
| Description conventions | rda |
| 041 0# - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| Language code of summary or abstract | eng |
| -- | ara |
| 049 ## - Acquisition Source | |
| Acquisition Source | Deposit |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.65 |
| 092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) | |
| Classification number | 616.65 |
| Edition number | 21 |
| 097 ## - Degree | |
| Degree | Ph.D |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
| Local Call Number | Cai01.11.34.Ph.D.2024.Ha.C |
| 100 0# - MAIN ENTRY--PERSONAL NAME | |
| Authority record control number or standard number | Hassan Ibrahim Fouad ElMosalamy, |
| Preparation | preparation. |
| 245 10 - TITLE STATEMENT | |
| Title | Comparison between convective radiofrequency water vapor thermal ablation (REZUM) versus tamsulosin in management of lower urinary tract symptoms in patients with benign prostatic enlargement / |
| Statement of responsibility, etc. | by Hassan Ibrahim Fouad ElMosalamy ; Supervised Prof. Dr. Alaa Meshref, Prof. Dr. Mohammed Abdou Abd El-Rassoul, Dr. Mohammed Wagieh Bassiony. |
| 246 15 - VARYING FORM OF TITLE | |
| Title proper/short title | دراسة مقارنة بين العلاج بالتبخير الحراري ببخار الماء (REZUM) مقابل تامسولوسين في علاج أعراض المسالك البولية السفلية لدى المرضى الذين يعانون من تضخم البروستاتا الحميد |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 2024 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 70 pages : |
| Other physical details | illustrations ; |
| Dimensions | 25 cm. + |
| Accompanying material | CD. |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Source | rda content |
| 337 ## - MEDIA TYPE | |
| Media type term | Unmediated |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | volume |
| Source | rdacarrier |
| 502 ## - DISSERTATION NOTE | |
| Dissertation note | Thesis (Ph.D)-Cairo University, 2024. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Bibliography: pages 63-70. |
| 520 #3 - SUMMARY, ETC. | |
| Summary, etc. | Background: Objective. This was a randomized controlled trial conducted on 94 patients with benign prostatic hyperplasia (BPH); to assess the efficacy of REZUM water vapor thermal ablation therapy against the conventional medical treatment for benign prostatic hyperplasia using tamsulosin.<br/>Patients and Methods: Results from the treatment arm of a randomized, clinical trial investigating water vapour therapy of prostate was compared to the results of single therapy arm, receiving Tamsulosin, restricted only to those subjects with prostate volume between 30cc – 80cc and IPSS 13 or worse. IPSS, uroflowmetry( Qmax), and PVR were compared at 3 months, 6 months and 1 year. <br/>Results: Regarding basic clinical data; the mean age of all patients was (70 ± 4.4) years, and the average BMI was (26 ± 2.2), with (9.6%) of patients having prior surgery. Regarding complications rate; (70.2%) of patients had suffered complications. The 94 BPH patients were classified according to management into 2 independent groups: Rezum group (47 patients) and Tamsulosin group (47 patients). Comparative study between the 2 groups of patients revealed the following; <br/>• Non-significant difference as regards all baseline data (p > 0.05).<br/>• Highly significant decrease in 3 ,6 and 12-months IPSS score, QOL IPSS score, PVR, and Prostate volume, in Rezum group; compared to Tamsulosin group (p < 0.01 respectively).<br/>• Highly significant increase in 3, 6 and 12-months Qmax, in Rezum group; compared to Tamsulosin group (p < 0.001).<br/>• Highly significant decrease in complications rate in Rezum group; compared to Tamsulosin group (p = 0.0017).<br/>Conclusion To conclude, our study had proven that, REZUM water vapor thermal ablation therapy showed high efficacy in patients with benign prostatic hyperplasia (BPH), in comparison with the conventional medical treatment using Tamsulosin, especially in IPSS score, Qmax, prostate volume, PVR and quality of life assessments through 12 months of regular follow up |
| 520 #3 - SUMMARY, ETC. | |
| Summary, etc. | يمثل ضعف تدفق البول نتيجة تضخم البروستاتا الحميد مشكلة شائعة بين الرجال مع تقدم السن. ويعاني أكثر من 50% من الرجال الذين تبلغ أعمارهم 60 عامًا أو أكثر من تضخم البروستاتا، كما يقترب هذا العدد من 90% لدى الأشخاص الذين تزيد أعمارهم عن 85 عامًا.<br/>كانت هذه دراسة مقارنة أجريت علي 94 مريضًا يعانون من انسداد مخرج المثانة (BOO) بسبب تضخم البروستاتا الحميد (BPH)؛ لتقييم النتائج مع تبخير البروستاتا ببخار الماء بتقنية الريزوم واستخدام العلاج الدوائي باستخدام عقار التامسولوسين 0.4 مجم .<br/>شملت الدراسة 94 مريضًا يعانون من اعراض انسدادية (التقييم الدولي لأعراض البروستاتا(IPSS) < 13) بسبب تضخم البروستاتا الحميد وحجم البروستاتا يتراوح بين 30 الي 80 جم. سبعة واربعون مريضا (المجموعة أ) خضعوا لتبخير البروستاتا بتقنية الريزوم (Rezum) و سبعة واربعون مريضا (المجموعة ب) خضعوا للعلاج الدوائي باستخدام تامسولوسين 0.4 مجم.<br/>قبل بدء الدراسة تم تقييم IPSS)) ،حجم البروستاتا ، مقياس تدفق البول (Qmax)وحجم البول المتبقي في المثانة بعد التبول (PVR).<br/>تمت المتابعة بعد ثلاثة أشهر ,ستة أشهر وسنة تم تقييم IPSS، Qmax ,PVR وحجم البروستاتا.<br/>وشملت النتائج الأولية النتيجة المحيطة بالعملية، والنتيجة أثناء العملية، والنتيجة الوظيفية بعد العملية وأثناء المتابعة |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE | |
| Issues CD | Issues also as CD. |
| 546 ## - LANGUAGE NOTE | |
| Text Language | Text in English and abstract in Arabic & English. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prostate Diseases. |
| 653 #1 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | BPH |
| -- | BOO |
| -- | Rezum |
| -- | Tamsulosin |
| -- | IPSS |
| -- | ENLARGED PROSTATE |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alaa Meshref |
| Relator term | thesis advisor. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mohammed Abdou Abd El-Rassoul |
| Relator term | thesis advisor. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mohammed Wagieh Bassiony |
| Relator term | thesis advisor. |
| 900 ## - Thesis Information | |
| Grant date | 01-01-2024 |
| Supervisory body | Alaa Meshref |
| -- | Mohammed Abdou Abd El-Rassoul |
| -- | Mohammed Wagieh Bassiony |
| Universities | Cairo University |
| Faculties | Faculty of Medicine |
| Department | Department of Urology |
| 905 ## - Cataloger and Reviser Names | |
| Cataloger Name | Shimaa |
| Reviser Names | Eman Ghareb |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Thesis |
| Edition | 21 |
| Suppress in OPAC | No |
| Source of classification or shelving scheme | Home library | Current library | Date acquired | Inventory number | Full call number | Barcode | Date last seen | Effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | المكتبة المركزبة الجديدة - جامعة القاهرة | قاعة الرسائل الجامعية - الدور الاول | 16.08.2025 | 91879 | Cai01.11.34.Ph.D.2024.Ha.C | 01010110091879000 | 16.08.2025 | 16.08.2025 | Thesis |